Table 5.
Advantages | Disadvantages |
---|---|
Available methods for NBS on DBS | Enzyme based assays do not identify many female heterozygotes. |
Approved treatments | Higher than expected numbers of later onset forms |
Importance of early diagnosis and treatment, often delayed clinical diagnosis | Lack of definite guidelines for follow up and start therapy especially for later onset forms |
Better knowledge of the natural history | Frequent detection of VUS or benign variants |
Genetic counseling | Phenotype prediction can be difficult |
Family screening | |
High incidence, more frequent than previously expected |
Abbreviations: DBS: dried blood spot, NBS: newborn screening, VUS: variant of uncertain significance.